Phenylpropenamide derivatives as inhibitors of Hepatitis B virus replication
Authors:
- Robert B PerniRPRobert B Perni
- Samuel C ConwaySCSamuel C Conway
- Stephanie K LadnerSLStephanie K Ladner
- Katie ZaifertKZKatie Zaifert
- Michael J OttoMOMichael J Otto
- Robert W KingRKRobert W King
- 1 December 2000
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 10 (23) , 2687-2690
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- In Vitro Antihepadnaviral Activities of Combinations of Penciclovir, Lamivudine, and AdefovirAntimicrobial Agents and Chemotherapy, 2000
- New Antiviral Agents for the Therapy of Chronic Hepatitis B Virus InfectionIntervirology, 1999
- Cell-Based and Animal Models for Hepatitis B and C VirusesAntiviral Chemistry and Chemotherapy, 1999
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- α‐Glucosidase inhibitors as potential broad based anti‐viral agentsFEBS Letters, 1998
- Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replicationAntimicrobial Agents and Chemotherapy, 1997
- The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineAntimicrobial Agents and Chemotherapy, 1992
- Long-term follow-up of anti-HBe-positive chronic active hepatitis BHepatology, 1988
- AZLACTONE OF a-BENZOYLAMINO-b-(3,4-DIMETHOXYPHENYL)-ACRYLIC ACIDOrganic Syntheses, 1933
- Ueber die Azlactone aus Furfurol resp. Salicylaldehyd und HippursäureEuropean Journal of Organic Chemistry, 1904